Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Bioconjug Chem ; 30(6): 1734-1744, 2019 06 19.
Artículo en Inglés | MEDLINE | ID: mdl-31091078

RESUMEN

Monitoring the assembly of macromolecules to design entities with novel properties can be achieved either chemically creating covalent bonds or by noncovalent connections using appropriate structural motifs. In this report, two self-associating peptides (named K3 and E3) that originate from p53 tetramerization domain were developed as tools for highly specific and noncovalent heterotetramerization of two biomolecules. The pairing/coupling preferences of K3 and E3 were first evaluated by molecular modeling data and confirmed using circular dichroism spectroscopy, size-exclusion chromatography, and biological assays. Regardless of the moieties fused to K3 and E3, these two peptides self-assembled into dimers of dimers to form bivalent heterotetrameric complexes that proved to be extremely stable inside living cells. The benefits of the multivalency in terms of avidity, specificity, and expanded functional activity were strikingly revealed when the proliferating cell nuclear antigen (PCNA), which is essential for DNA replication, was targeted using a heterotetramer presenting both an antibody fragment against PCNA and a specific PCNA binder peptide. In vitro heterotetramerization of these two known PCNA ligands increased their binding efficiencies to PCNA up to 80-fold compared to the best homotetramer counterpart. In cellulo, the heterotetramers were able to efficiently inhibit DNA replication and to trigger cell death. Altogether, we demonstrate that these two biselective self-assembling peptidic domains offer a versatile noncovalent conjugation method that can be easily implemented for protein engineering.


Asunto(s)
Péptidos/química , Antígeno Nuclear de Célula en Proliferación/química , Proteína p53 Supresora de Tumor/química , Línea Celular Tumoral , ADN/química , Replicación del ADN , Humanos , Modelos Moleculares , Dominios Proteicos , Multimerización de Proteína
2.
World Allergy Organ J ; 16(7): 100801, 2023 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-37520615

RESUMEN

Background: Pollen variation can affect field study data quality. Nasal allergen challenge (NAC) is considered the gold standard for evaluating allergic rhinitis, while environmental exposure chambers (EECs) are mainly used in phase 2 drug development studies. We aimed to study birch-induced allergic rhinitis under 3 different conditions. Methods: This study included 30 participants allergic to birch pollen, based on birch skin prick test, specific immunoglobulin E (IgE), and positive NAC. Participants were exposed to placebo twice, followed by 2 consecutive 4-h birch airborne exposures, repeated on 2 occasions to evaluate reproducibility and priming effect. Nasal response was defined as total corrected nasal symptom score (ΔTNSS) ≥ 5 during NAC and EEC. The primary end-point was to measure TNSS during the last 2 h of first allergen exposure. TNSS was also analyzed during natural exposure. Results: The dose most commonly yielding positive TNSS during NAC was 175.2 ng/200 µL. Eighteen participants experienced ΔTNSS ≥5 during the last 2 h of the first exposure, whereas 21 had positive responses at all 4 exposures. Mean ΔTNSS was 1 with placebo versus 6 with birch. Exposures were reproducible, with no observed priming effect. Airborne Bet v 1 was 25 ng/m3, while the pollen measurement was 279/m3 during pollen season. TNSS reached 5 in 67.9% of participants during peak pollen season. Conclusion: EEC outcomes were similar to those obtained with NAC and natural exposure, suggesting the usefulness of EEC in allergic rhinitis studies. The primary end-point was reached, as 60% of participants experienced nasal responses.

3.
J Immunol Methods ; 498: 113144, 2021 11.
Artículo en Inglés | MEDLINE | ID: mdl-34481824

RESUMEN

Bivalent VHHs have been shown to display better functional affinity compared with their monovalent counterparts. Bivalency can be achieved either by inserting a hinge region between both VHHs units or by using modules that lead to dimerization. In this report, a small self-associating peptide originating from the tetramerization domain of p53 was developed as a tool for devicing nanobody dimerization. This E3 peptide was evaluated for the dimerization of an anti-eGFP nanobody (nano-eGFP-E3) whose activity was compared to a bivalent anti-eGFP constructed in tandem using GS rich linker. The benefit of bivalency in terms of avidity and specificity was assessed in different in vitro and in cellulo assays. In ELISA and SPR, the dimeric and tandem formats were nearly equivalent in terms of gain of avidity compared to the monovalent counterpart. However, in cellulo, the nano-eGFP-E3 construct showed its superiority over the tandem format in terms of specificity with a highest and better ratio signal-to-noise. All together, the E3 peptide provides a universal suitable tool for the construction of dimeric biomolecules, in particular antibody fragments with improved functional affinity.


Asunto(s)
Epítopos , Proteínas Fluorescentes Verdes/inmunología , Fragmentos de Péptidos/inmunología , Anticuerpos de Dominio Único/inmunología , Proteína p53 Supresora de Tumor/inmunología , Animales , Afinidad de Anticuerpos , Especificidad de Anticuerpos , Proteínas Fluorescentes Verdes/genética , Células HeLa , Humanos , Mutación , Fragmentos de Péptidos/genética , Multimerización de Proteína , Proteína p53 Supresora de Tumor/genética
4.
Biotechniques ; 62(2): 80-82, 2017 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-28193152

RESUMEN

Here we developed a complementation method for the study of essential genes in live human cells using the CRISPR/Cas9 system. Proteins encoded by essential genes were expressed using a derivative of the pCEP4 compensating plasmid in combination with Cas9 endonuclease targeting of the chromosomal genes. We show that this strategy can be applied to essential genes, such as those coding for proliferating cell nuclear antigen (PCNA) and DNA polymerase delta subunit 2 (POLD2). As demonstrated for the PCNA protein, our method allows mutational analysis of essential protein-coding sequences in live cells.


Asunto(s)
Sistemas CRISPR-Cas/genética , Análisis Mutacional de ADN/métodos , Genes Esenciales/genética , Prueba de Complementación Genética/métodos , Técnicas Citológicas , Técnicas de Inactivación de Genes , Humanos , Modelos Moleculares , Mutación/genética , Antígeno Nuclear de Célula en Proliferación/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA